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Abstract (119 words)  
Multisite phosphorylation regulates many transcription factors, including the Serum 
Response Factor partner Elk-1. Phosphorylation of the transcriptional activation domain 
(TAD) of Elk-1 by the protein kinase ERK at multiple sites potentiates recruitment of the 
Mediator transcriptional coactivator complex and transcriptional activation, but the roles 
of individual phosphorylation events remained unclear. Using time-resolved nuclear 
magnetic resonance spectroscopy, we found that ERK2 phosphorylation proceeds at 
markedly different rates at eight TAD sites in vitro, which we classified as fast, 
intermediate and slow. Mutagenesis experiments showed that phosphorylation of fast and 
intermediate sites promoted Mediator interaction and transcriptional activation, whereas 
modification of slow sites counteracted both functions, thereby limiting Elk-1 output. 
Progressive Elk-1 phosphorylation thus ensures a self-limiting response to ERK 
activation, which occurs independently of antagonizing phosphatase activity.   
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RESULTS AND DISCUSSION 
Multisite protein phosphorylation increases the complexity of functional signaling 
outputs that can be generated from single protein kinase inputs. It can set thresholds for 
activity, or transform graded signals into switch-like responses (1-4). Many transcription 
factors and their interacting regulatory proteins are subject to multisite phosphorylation, 
which allows distinct aspects of protein function, including protein turnover, nuclear 
import and export, and specific protein interactions, to be controlled independently (5). 
However, in general, the dynamics and functional roles of individual phosphorylation 
events are incompletely understood. 
 The ternary complex factor (TCF) subfamily of Ets-domain transcription factors, 
consisting of Elk-1, SAP-1, and Net, provides an example of multisite phosphorylation in 
transcriptional activation. TCFs, together with their partner protein SRF, function in 
many biological processes by coupling SRF target genes to mitogen-activated protein 
kinase (MAP kinase) signaling (5). Mitogenic and stress stimuli induce phosphorylation 
of TCF C-terminal transcriptional activation domains (TADs) at multiple S/T-P (Ser- or 
Thr-Pro) phosphorylation sequences, of which eight are conserved across the family (Fig. 
1A; fig. S1) (6-11). Two MAP kinase-docking sites, the D-box and the Phe-Gln-Phe-Pro 
(FQFP) motif, control phosphorylation of these sites (12-15). Multisite phosphorylation 
triggers transcriptional activation by TCFs, facilitating their interaction with the Mediator 
transcriptional co-activator complex (16-19) but the kinetics with which the different 
sites are phosphorylated, and whether they serve distinct functions, remain unclear.  
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To obtain atomic-resolution insights into phosphorylation of the Elk-1 TAD, we 
used nuclear magnetic resonance (NMR) spectroscopy (20) to monitor its modification 
by recombinant ERK2 in vitro (Fig. 1B; fig. S2A). Time-resolved NMR experiments 
revealed that each phosphorylation proceeded efficiently, but at markedly different rates. 
Phosphorylation of Thr369 and Ser384, which flank the central Phe–Trp (FW) motif 
implicated in Mediator interaction (18), occurred faster than modification of Thr364, 
Thr354 and Ser390, whereas residues Thr418, Ser423 and Thr337 were modified more slowly 
(Fig. 1C), which we confirmed by immunoblotting (Fig. 1D). Chemical shift analysis 
(Cα, Cβ) showed no stable secondary structure elements in unmodified or 
phosphorylated Elk-1 TAD (fig. S2B). 
As a first step towards understanding the basis for the phosphorylation sites' 
differential kinetic behavior, we devised a reaction model based on Michaelis-Menten 
enzyme kinetics. To simplify the mathematical treatment, we grouped Elk-1 sites into 
three classes: fast (Thr369 and Ser384), intermediate (Thr354, Thr364, and Ser390) and slow 
(Thr337, Thr418, and Ser423). We assumed that ERK2 phosphorylation is distributive, that 
enzymatic rate constants (kcat) are similar for all sites, and that the different sites have 
relative affinities for ERK2 modeled by increasing Michaelis-Menten constants (KMFast < 
KMInt < KMSlow)(Fig. 2A, fig. S3A, 20). This model, which recapitulated the measured 
kinetics of in vitro Elk-1 phosphorylation well (Fig. 2B) predicted that removal of fast or 
intermediate sites should increase the phosphorylation rates of other sites. To test this 
idea, we analyzed the phosphorylation kinetics of Elk-1 TAD mutants in which we 
substituted all fast or intermediate phosphoacceptor residues with alanines (Elk-1F: 
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Thr369!Ala,  Ser384!Ala; Elk-1I: Thr354!Ala, Thr364!Ala, and Ser390!Ala)(Fig. 2A). 
In the fast site mutant Elk-1F, phosphorylation rates of intermediate and slow sites 
increased, whereas those of the fast and slow sites increased in the intermediate-site 
mutant Elk-1I; in both cases the altered kinetics fit well with those predicted by the 
model (Fig 2B, fig. S3B). Thus, even the fast sites are not phosphorylated at the 
maximum possible rate in the wildtype protein. Moreover, phosphorylation of an Elk-1 
TAD mutant in which Thr369 and Ser384 were replaced with aspartates was similar to Elk-
1F, excluding the possibility that fast-site phosphorylation primes later modification 
events (fig. S3B).  
To gain more insight into the factors affecting individual sites' phosphorylation 
kinetics, we assessed the role played by primary sequence. To do this, we exchanged the 
sequences surrounding the fast Thr369 and slow Ser423 sites. This also effectively 
exchanged their reactivities, which suggests that these sites' phosphorylation rates reflect 
their position relative to ERK docking sequences, rather than intrinsic differences in 
reactivity (Fig. 2C). We therefore examined the contributions of the D-box and FQFP 
ERK docking motifs to each site's phosphorylation kinetics. Deletion of the D-box 
decreased the rates of Thr337, Thr354, Thr364 and Thr369 phosphorylation, but increased the 
rates of Ser390, Thr418, and Ser423 modification (Fig. 2D). In contrast, deletion of the 
FQFP motif decreased the rate of Ser384 phosphorylation, but enhanced modification of 
intermediate sites, including adjacent Ser390, with no effect on the C-terminal sites (Fig. 
2D). Thus, the ERK docking motifs differentially affect each phosphorylation site's 
competitive behavior. Previous studies showed that Elk-1 TAD phosphorylation by JNK 
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and p38 MAP kinase differs from phosphorylation by ERK (10, 21-24), and that this 
reflects differences in their docking interactions (12, 14, 15, 25). Indeed, these kinases 
exhibited site preferences and phosphorylation rates that were distinct from that of ERK2 
(fig. S3C). Taken together, our results show that the different rates of Elk-1 TAD 
phosphorylation by ERK2 follow a competition mechanism that is governed by the 
position of individual Elk-1 substrate sites relative to ERK2 docking interactions. 
 To test whether the different kinetic classes of Elk-1 TAD phosphorylation sites 
are functionally equivalent, we expressed mouse Elk-1 mutants in fibroblasts derived 
from TCF-deficient (Elk1-/-;Elk3δ/δ;Elk4-/-) triple-knockout mouse embryos (TKO MEFs; 
fig. S4, A-C). In these cells, immediate-early (IE) gene expression is defective, but 
expression of wild-type mouse Elk-1 restored the IE transcriptional activation seen in 
wild-type MEFs after activation of ERK by treatment with TPA (12-O-
tetradecanoylphorbol-13-acetate) (fig. S4D). As expected, alanine substitutions of fast 
and/or intermediate sites, or of the FW motif, greatly diminished or abolished the ability 
of Elk-1 to activate TCF-SRF target gene transcription after TPA stimulation (Fig. 3A; 
fig. S4D). Surprisingly, however, mutation of the slow sites substantially enhanced Elk-
1-mediated activation of TCF-SRF target genes (Fig. 3A). Alanine substitutions at 
individual slow sites also increased Elk-1 activity, with Thr418 exhibiting the greatest 
effect (Fig. 3B, fig. S4, E-G). TCF-SRF signaling is important for cellular proliferation 
(26, 27), and TKO MEFs proliferate more slowly than wildtype MEFs. The reconstituted 
TKO MEFs exhibited enhanced proliferation rates, which correlated with the ability of 
each mutant to promote transcriptional activation (Fig. 3C).  
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 Phosphorylation of Elk-1 promotes transcriptional activation by facilitating its 
MED23-dependent interaction with the Mediator complex (16-18). We therefore 
investigated whether the different transcriptional activities of the Elk-1 mutants reflected 
alterations in Mediator binding. We prepared extracts of TKO cells expressing wildtype 
or mutant Elk-1 proteins and assessed Elk-1 assocation with Mediator by co-
immunoprecipitation of the MED23, MED24 and MED16 subunits. Consistent with the 
transcription experiments, Elk-1–Mediator interaction was induced by TPA stimulation 
and dependent on the FW motif; it was abolished by alanine substitutions of fast and 
intermediate sites, and was increased in the slow-site Elk-1 mutant (Fig. 3D). We 
obtained similar results when we used glutathione S-transferase (GST)-Elk-1 TAD 
proteins to recover Mediator proteins from unstimulated NIH3T3 cell extracts (Fig. 3E). 
In this assay, ERK2 phosphorylation time-course experiments showed that Mediator 
recovery by the wildtype Elk-1 TAD was most efficient prior to modifications of the slow 
sites (fig. S5, A and B). Taken together, these data show that according to the sites 
involved, ERK2 phosphorylation promotes or inhibits transcriptional activation by Elk-1, 
which reflects alterations in Elk-1–Mediator interactions.  
Next, we investigated Elk-1 TAD phosphorylation kinetics in vivo. Previous studies 
were unable to distinguish the progressive phosphorylation of fast and slow Elk-1 sites 
(6). However, by incubating cells at 25° C to slow down reactions, we confirmed that 
phosphorylation rates can be ranked in the order Ser384>Thr364>Thr418, and that different 
site classes exhibited a similar competitive behavior, as seen in vitro (fig. S6A). 
Reasoning that phosphorylation of the Elk-1 TAD might be sensitive to kinetic effects at 
limiting signal strengths, we titrated ERK activity using increasing amounts of TPA. This 
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both increased the maximal extent of ERK activation and advanced the time at which it 
occurred (fig. S6B). At low TPA concentrations, Elk-1 fast-site (Thr384) and slow-site 
(Thr418)-site modifications accumulated slowly over 1 hour, whereas at a saturating TPA 
dose they were maximal by 10 minutes. Both phosphorylations declined at late times, 
presumably owing to the action of Elk-1 phosphatases (Fig. 4A)(6, 28).  
Having established that Elk-1 phosphorylation kinetics are tuned by signal strength, 
we investigated their relationship to transcriptional activation. We compared the ability of 
wildtype Elk-1 and the slow-site mutant Elk-1S to activate transcription in response to 
signals of differing strengths. At saturating TPA concentrations, both proteins activated 
Egr1 transcription with similar transient kinetics, although Elk-1S was much more active, 
reflecting the loss of the inhibitory sites (Fig. 4, B and C). At limiting TPA doses, 
however, their behaviors were markedly different. Whereas the activity of wildtype Elk-1 
was almost maximal by 15 minutes, that of Elk-1S increased substantially beyond this 
time (Fig. 4B), resulting in prolonged Egr1 mRNA accumulation (Fig. 4C). Thus, 
progressive phosphorylation of the Elk-1 TAD by a single kinase, ERK, attenuates the 
transcriptional response of Elk-1, shaping it according to the strength and kinetics of 
ERK activation. 
 Our results show that phosphorylation of the Elk-1 TAD by a single kinase, ERK, 
can either promote or inhibit Mediator interaction, depending on the sites involved, 
thereby modulating transcriptional activation. Given that the TAD sequences are 
conserved in the other TCFs, our findings may also apply to them. The more rapidly 
phosphorylated sites are located in the substantially conserved central core of the TAD, 
and are essential for transcriptional activation, lying close to the FW hydrophobic motif 
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required for Elk-1–Mediator interaction (10, 18). Multisite phosphorylation of these 
residues might stabilize this interaction, and perhaps also set a signaling threshold for it, 
similar to the way that multisite phosphorylation sets a threshold for the Sic1–Cdc4 
interaction (29). In contrast, slowly phosphorylated sites located N- and C-terminal of the 
conserved TAD core act negatively. Their phosphorylation inhibits Mediator recruitment 
and limits transcriptional activation (Fig 4D), and may also facilitate recruitment of 
negative regulators of Elk-1 activity. Together these properties ensure that ERK 
phosphorylation of the Elk-1 TAD is self-limiting, whereby phosphorylation of slow sites 
attenuates TCF-SRF target gene expression under conditions of strong or sustained ERK 
signaling (Fig. 4D). Our results challenge the common assumption that multisite 
modification events act unidirectionally and can only be reversed or limited by 
antagonistic enzymes. Given the prevalence of such events in different biological 
processes, we expect that similar mechanisms may govern other regulatory interactions. 
	 10	
REFERENCES  
1. J. Gunawardena, Multisite protein phosphorylation makes a good threshold but 
can be a poor switch. Proceedings of the National Academy of Sciences of the 
United States of America 102, 14617-14622 (2005); published online EpubOct 11 
(10.1073/pnas.0507322102). 
2. J. Gunawardena, Distributivity and processivity in multisite phosphorylation can 
be distinguished through steady-state invariants. Biophysical journal 93, 3828-
3834 (2007); published online EpubDec 1 (10.1529/biophysj.107.110866). 
3. C. Salazar, T. Hofer, Multisite protein phosphorylation--from molecular 
mechanisms to kinetic models. The FEBS journal 276, 3177-3198 (2009); 
published online EpubJun (10.1111/j.1742-4658.2009.07027.x). 
4. X. Liu, L. Bardwell, Q. Nie, A combination of multisite phosphorylation and 
substrate sequestration produces switchlike responses. Biophysical journal 98, 
1396-1407 (2010); published online EpubApr 21 (10.1016/j.bpj.2009.12.4307). 
5. M. Karin, T. Hunter, Transcriptional control by protein phosphorylation: signal 
transmission from the cell surface to the nucleus. Current biology : CB 5, 747-757 
(1995). 
6. F. H. Cruzalegui, E. Cano, R. Treisman, ERK activation induces phosphorylation 
of Elk-1 at multiple S/T-P motifs to high stoichiometry. Oncogene 18, 7948-7957 
(1999); published online EpubDec 23 (10.1038/sj.onc.1203362). 
	 11	
7. R. Janknecht, W. H. Ernst, V. Pingoud, A. Nordheim, Activation of ternary 
complex factor Elk-1 by MAP kinases. The EMBO journal 12, 5097-5104 (1993). 
8. R. Marais, J. Wynne, R. Treisman, The SRF accessory protein Elk-1 contains a 
growth factor-regulated transcriptional activation domain. Cell 73, 381-393 
(1993). 
9. R. Janknecht, W. H. Ernst, A. Nordheim, SAP1a is a nuclear target of signaling 
cascades involving ERKs. Oncogene 10, 1209-1216 (1995). 
10. M. A. Price, A. E. Rogers, R. Treisman, Comparative analysis of the ternary 
complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET). The EMBO journal 14, 
2589-2601 (1995). 
11. H. Gille, M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M. H. Cobb, P. 
E. Shaw, ERK phosphorylation potentiates Elk-1-mediated ternary complex 
formation and transactivation. The EMBO journal 14, 951-962 (1995). 
12. D. A. Fantz, D. Jacobs, D. Glossip, K. Kornfeld, Docking sites on substrate 
proteins direct extracellular signal-regulated kinase to phosphorylate specific 
residues. The Journal of biological chemistry 276, 27256-27265 (2001); 
published online EpubJul 20 (10.1074/jbc.M102512200). 
13. S. H. Yang, P. R. Yates, A. J. Whitmarsh, R. J. Davis, A. D. Sharrocks, The Elk-1 
ETS-domain transcription factor contains a mitogen-activated protein kinase 
targeting motif. Molecular and cellular biology 18, 710-720 (1998). 
	 12	
14. S. H. Yang, A. J. Whitmarsh, R. J. Davis, A. D. Sharrocks, Differential targeting 
of MAP kinases to the ETS-domain transcription factor Elk-1. The EMBO journal 
17, 1740-1749 (1998); published online EpubMar 16 (10.1093/emboj/17.6.1740). 
15. D. Jacobs, D. Glossip, H. Xing, A. J. Muslin, K. Kornfeld, Multiple docking sites 
on substrate proteins form a modular system that mediates recognition by ERK 
MAP kinase. Genes & development 13, 163-175 (1999). 
16. J. L. Stevens, G. T. Cantin, G. Wang, A. Shevchenko, A. Shevchenko, A. J. Berk, 
Transcription control by E1A and MAP kinase pathway via Sur2 mediator 
subunit. Science 296, 755-758 (2002); published online EpubApr 26 
(10.1126/science.1068943). 
17. G. Wang, M. A. Balamotis, J. L. Stevens, Y. Yamaguchi, H. Handa, A. J. Berk, 
Mediator requirement for both recruitment and postrecruitment steps in 
transcription initiation. Molecular cell 17, 683-694 (2005); published online 
EpubMar 4 (10.1016/j.molcel.2005.02.010). 
18. M. A. Balamotis, M. A. Pennella, J. L. Stevens, B. Wasylyk, A. S. Belmont, A. J. 
Berk, Complexity in transcription control at the activation domain-mediator 
interface. Science signaling 2, ra20 (2009)10.1126/scisignal.1164302). 
19. W. Wang, L. Huang, Y. Huang, J. W. Yin, A. J. Berk, J. M. Friedman, G. Wang, 
Mediator MED23 links insulin signaling to the adipogenesis transcription 
cascade. Developmental cell 16, 764-771 (2009); published online EpubMay 
(10.1016/j.devcel.2009.04.006). 
	 13	
20. F. X. Theillet, H. M. Rose, S. Liokatis, A. Binolfi, R. Thongwichian, M. Stuiver, 
P. Selenko, Site-specific NMR mapping and time-resolved monitoring of serine 
and threonine phosphorylation in reconstituted kinase reactions and mammalian 
cell extracts. Nature protocols 8, 1416-1432 (2013)10.1038/nprot.2013.083). 
21. M. Cavigelli, F. Dolfi, F. X. Claret, M. Karin, Induction of c-fos expression 
through JNK-mediated TCF/Elk-1 phosphorylation. The EMBO journal 14, 5957-
5964 (1995). 
22. H. Gille, T. Strahl, P. E. Shaw, Activation of ternary complex factor Elk-1 by 
stress-activated protein kinases. Current biology : CB 5, 1191-1200 (1995). 
23. A. J. Whitmarsh, P. Shore, A. D. Sharrocks, R. J. Davis, Integration of MAP 
kinase signal transduction pathways at the serum response element. Science 269, 
403-407 (1995). 
24. M. A. Price, F. H. Cruzalegui, R. Treisman, The p38 and ERK MAP kinase 
pathways cooperate to activate Ternary Complex Factors and c-fos transcription 
in response to UV light. The EMBO journal 15, 6552-6563 (1996). 
25. D. L. Sheridan, Y. Kong, S. A. Parker, K. N. Dalby, B. E. Turk, Substrate 
discrimination among mitogen-activated protein kinases through distinct docking 
sequence motifs. The Journal of biological chemistry 283, 19511-19520 (2008); 
published online EpubJul 11 (10.1074/jbc.M801074200). 
26. E. R. Vickers, A. Kasza, I. A. Kurnaz, A. Seifert, L. A. Zeef, A. O'Donnell, A. 
Hayes, A. D. Sharrocks, Ternary complex factor-serum response factor complex-
regulated gene activity is required for cellular proliferation and inhibition of 
	 14	
apoptotic cell death. Molecular and cellular biology 24, 10340-10351 (2004); 
published online EpubDec (10.1128/MCB.24.23.10340-10351.2004). 
27. M. A. Wozniak, C. Q. Cheng, C. J. Shen, L. Gao, A. O. Olarerin-George, K. J. 
Won, J. B. Hogenesch, C. S. Chen, Adhesion regulates MAP kinase/ternary 
complex factor exchange to control a proliferative transcriptional switch. Current 
biology : CB 22, 2017-2026 (2012); published online EpubNov 6 
(10.1016/j.cub.2012.08.050). 
28. T. Sugimoto, S. Stewart, K. L. Guan, The calcium/calmodulin-dependent protein 
phosphatase calcineurin is the major Elk-1 phosphatase. The Journal of biological 
chemistry 272, 29415-29418 (1997). 
29. P. Nash, X. Tang, S. Orlicky, Q. Chen, F. B. Gertler, M. D. Mendenhall, F. 
Sicheri, T. Pawson, M. Tyers, Multisite phosphorylation of a CDK inhibitor sets a 
threshold for the onset of DNA replication. Nature 414, 514-521 (2001); 
published online EpubNov 29 (10.1038/35107009). 
30. M. K. Vartiainen, S. Guettler, B. Larijani, R. Treisman, Nuclear actin regulates 
dynamic subcellular localization and activity of the SRF cofactor MAL. Science 
316, 1749-1752 (2007); published online EpubJun 22 (10.1126/science.1141084). 
31. A. Ayed, F. A. Mulder, G. S. Yi, Y. Lu, L. E. Kay, C. H. Arrowsmith, Latent and 
active p53 are identical in conformation. Nature structural biology 8, 756-760 
(2001); published online EpubSep (10.1038/nsb0901-756). 
	 15	
32. K. Tamiola, B. Acar, F. A. Mulder, Sequence-specific random coil chemical shifts 
of intrinsically disordered proteins. Journal of the American Chemical Society 
132, 18000-18003 (2010); published online EpubDec 29 (10.1021/ja105656t). 
33. K. Tamiola, F. A. Mulder, Using NMR chemical shifts to calculate the propensity 
for structural order and disorder in proteins. Biochemical Society transactions 40, 
1014-1020 (2012); published online EpubOct (10.1042/BST20120171). 
34. S. Schwarzinger, G. J. Kroon, T. R. Foss, J. Chung, P. E. Wright, H. J. Dyson, 
Sequence-dependent correction of random coil NMR chemical shifts. Journal of 
the American Chemical Society 123, 2970-2978 (2001). 
35. E. A. Bienkiewicz, K. J. Lumb, Random-coil chemical shifts of phosphorylated 
amino acids. Journal of biomolecular NMR 15, 203-206 (1999). 
36. G. Platzer, M. Okon, L. P. McIntosh, pH-dependent random coil (1)H, (13)C, and 
(15)N chemical shifts of the ionizable amino acids: a guide for protein pK a 
measurements. Journal of biomolecular NMR 60, 109-129 (2014); published 
online EpubNov (10.1007/s10858-014-9862-y). 
37. P. Patwardhan, W. T. Miller, Processive phosphorylation: mechanism and 
biological importance. Cellular signalling 19, 2218-2226 (2007); published online 
EpubNov (10.1016/j.cellsig.2007.06.006). 
38. M. Putz, A. Lacrama, V. Ostafe, Full Analytic Progress Curves of Enzymic 
Reactions in Vitro. Int. J. Mol. Sci. 7, 469-484 (2006). doi:10.3390/i7110469 
	 16	
39. F. X. Theillet, H. M. Rose, S. Liokatis, A. Binolfi, R. Thongwichian, M. Stuiver, 
P. Selenko, Corrigendum: Site-specific NMR mapping and time-resolved 
monitoring of serine and threonine phosphorylation in reconstituted kinase 
reactions and mammalian cell extracts. Nature protocols 11, 192 (2016); 
published online EpubJan (10.1038/nprot0116-192a). 
40. P. Costello, R. Nicolas, J. Willoughby, B. Wasylyk, A. Nordheim, R. Treisman, 
Ternary complex factors SAP-1 and Elk-1, but not net, are functionally equivalent 
in thymocyte development. Journal of immunology 185, 1082-1092 (2010); 
published online EpubJul 15 (10.4049/jimmunol.1000472). 
41. A. Mylona, R. Nicolas, D. Maurice, M. Sargent, D. Tuil, D. Daegelen, R. 
Treisman, P. Costello, The essential function for serum response factor in T-cell 
development reflects its specific coupling to extracellular signal-regulated kinase 
signaling. Molecular and cellular biology 31, 267-276 (2011); published online 
EpubJan (10.1128/MCB.01058-10). 
 
	 17	
ACKNOWLEDGEMENTS 
Work in the Treisman group was supported by the Francis Crick Institute, which receives 
its core funding from Cancer Research UK (FC001-190), the UK Medical Research 
Council (FC001-190) and the Wellcome Trust (FC001-190); and by European Research 
Council (ERC) advanced grant 268690 ACTINonSRF. Work in the Selenko group is 
funded by the ERC consolidator grant #647474 NeuroInCellNMR. F.-X.T. is supported 
by Agence Nationale pour la Recherche grant ANR14-ACHN-0015-01. The authors have 
no conflicts of interest. AM conceived the project; A.M., C.F., and F.M. designed and 
performed molecular and cell biology experiments; F.X.-T., T.C. and P.B. developed the 
competitive inhibition model; F.-X.T. and P.S. designed, executed and interpreted the 
NMR experiments, and A.M., P.S. and R.T. designed and interpreted experiments and 
wrote the paper. We thank F. Gualdrini, C. Esnault and P. Costello for characterising 
gene regulation in reconstituted TKO MEFs, sharing their unpublished data, and 
generating reconstituted TKO MEF cells; the Crick Genomics and Flow Cytometry 
technology platforms for technical support; and A. Behrens, V. Calleja, A. Chakraborty, 
M. Diefenbacher, C. Duellberg, R. Nicolas, P. Riou, M. Skehel, and our group members 
for advice and discussions. 
	 18	
SUPPPLEMENTARY MATERIALS 
Materials and Methods 
Figs. S1 to S6 
	 19	
FIGURE LEGENDS 
 
Figure 1. Multisite phosphorylation of Elk-1 TAD. (A) Linear outline of Elk-1 fast (red), 
intermediate (blue), and slow (yellow) S/T-P phosphorylation sites. Kinase docking 
motifs are shown in green; the FW residues (purple) are essential for Mediator 
association. (B) NMR analysis of Elk-1 TAD (amino acids 309 to 429) phosphorylation 
with recombinant ERK2. Left: 2D 1H-15N NMR spectrum of unphosphorylated Elk-1 
(black), with phosphorylation-site signals color-coded as in (A). Right: overlay of 2D 
NMR spectra of phosphorylated [grey & color-coded as in (A)] and unmodified Elk-1 
(black). (C) Time-resolved modification curves of individual Elk-1 sites upon 
phosphorylation with ERK2; error bars denote differences between replicate experiments 
on two independent samples.  (D) Time-course Western blot of GST-Elk-1 TAD 
phosphorylation and phosphorlyation-site-specific antibody detection. 
 
Figure 2. Phosphorylation kinetics of Elk-1 TAD mutants. (A) Outline of analyzed Elk-1 
TAD mutants. Substrate sites were classified as fast (red), intermediate (blue) or slow 
(yellow) for model calculations. (B) Left: comparison of averaged measured data points 
of wild-type Elk-1 TAD fast-, intermediate- and slow-site phosphorylation by ERK2 
(circles) with calculated rates according to the competitive inhibition model  (solid lines). 
Center: fast-site alanine-substituted Elk-1 TAD (Elk-1F); dashed lines show wildtype 
Elk-1 TAD for comparison. Right: intermediate-site alanine-substituted Elk-1 TAD (Elk-
1I); dashed lines show wildtype Elk-1 TAD for comparison. (C) Time-resolved 
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modification curves (right) of the Elk-1 369/423 switch mutant (left). Error bars denote 
differences between replicate experiments on two independent samples. (D) Time-
resolved modification curves of ERK docking-site mutants Elk-1ΔD-box (left) and Elk-
1ΔFQFP (right), presented as in (C). Effects of D-box and FQFP site deletions on Elk-1 
TAD phosphorylation rates are summarised below.  
 
Figure 3. Effects of Elk-1 TAD mutations on TCF target gene expression, cell 
proliferation and Mediator binding. (A) Quantitative reverse-transcription polymerase 
chain reaction (qRT-PCR) analysis of TCF target gene transcription in reconstituted TKO 
MEFs. Cells were reconstituted with wild-type mouse Elk-1 (WT) or fast-site (F), 
intermediate-site (I), slow-site (S), fast- and intermediate-site (FI) or alanine-substituted 
FW motif (FW) mutants. (B) Effects of individual slow-site alanine substitutions on Egr1 
expression. In (A) and (B) cells were stimulated with 50 ng/ml TPA where indicated. 
RNA levels are quantified relative to GAPDH; data are means ± SEM, n = 3. (C) 
Proliferation of wild-type and mutant Elk-1 TKO MEFs. Data are means ± SEM, n = 3. 
(D) Co-immunoprecipitation of Mediator with wildtype or mutant Flag-tagged Elk-1 
from NIH3T3 cell extracts. Antibodies to Mediator subunits MED23, MED24 and 
MED16 were used for immunoblotting. (E) Mediator co-precipitation from unstimulated 
NIH3T3 cell extracts using wild-type and mutant GST-tagged Elk-1 TAD proteins with 
and without prior ERK2 phosphorylation. 
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Figure 4. Multisite phosphorylation of Elk-1 shapes the transcriptional response to ERK 
activation. (A) Kinetics of Elk-1 fast- and slow-site phosphorylation in cells treated with 
increasing concentrations of TPA. (B) Transcription rate of the TCF-SRF target gene 
Egr1 in TKO MEFs expressing wildtype Elk-1 or mutant Elk-1S. Precursor RNA was 
monitored by qRT-PCR after stimulation with different concentrations of TPA. Data are 
mean ± SEM; n=3. (C) Kinetics of Egr1 mRNA accumulation in cells as in (B) 
monitored by qRT-PCR (D) Progressive Elk-1 phosphorylation by ERK has both 
activating (left and center) and inhibitory (right) effects on Mediator recruitment, as 
suggested by shading densities. A strong signal will rapidly reach the attenuated state 
shown at the right, a weak signal may reach this state only if sustained. 
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Materials and Methods 
Molecular techniques  
 Plasmid constructions, protein analysis by SDS-PAGE and immunoblotting, 
siRNA-mediated protein depletion, and cell proliferation analysis used standard methods. 
 
Recombinant GST-Elk-1 TAD.  
Wild-type or mutant mouse Elk-1 sequences encoding residues 309-429 were 
expressed as GST-(His)6 fusion proteins, inserted between BamHI and NotI sites of 
modified pET-41a (30). Protein expression was induced in E. coli BL21(DE3) (Novagen) 
with 0.5 mM IPTG at 37° C. Cells were lysed in 50 mM Tris pH 8.0, 300 mM NaCl, 5 
mM DTT, with Complete protease inhibitor cocktail (Roche Diagnostics). Cleared lysates 
were applied to glutathione Sepharose resin (GE Healthcare Life Sciences) and washed 
extensively with lysis buffer. Proteins were eluted with 20mM reduced glutathione in 50 
mM Tris pH 8.0, 150 mM NaCl, 5mM DTT, and further purified on a Superdex 200 
HR10/30 size exclusion column (GE Healthcare Life Sciences) in 20 mM K2HPO4 pH 
6.8, 150 mM NaCl, 5 mM DTT. For 15N- and 15N-/13C-labeling, growing cells were 
transferred to minimal medium containing 15NH4Cl and/or 13C-glucose as appropriate and 
grown at 30 °C. After adsorption to glutathione sepharose the Elk-1 moiety was released 
by incubation with 1:50 (w/w) GST-3C protease on the resin, and purified by Superdex 
75 HR10/30 size exclusion chromatography as above. For phosphorylation, GST-Elk-1 
TAD proteins (50µM) were incubated with 400 U ERK2 (NEB) in 100µl 10 mM 
K2HPO4  pH 6.9, 50 mM NaCl, 1 mM ATP, 2mM DTT, 5 mM MgCl2 at 25 °C.  
 
NMR spectroscopy 
 All NMR experiments were performed on a 750 MHz Bruker NMR spectrometer 
equipped with cryogenically cooled triple resonance probe (TCI). Resonance assignments 
for WT and mutant Elk-1 TAD were obtained by 2D 1H-15N HSQC and 3D HNCACB, 
HN(CA)CO, CA(CO)NNH, HNCO, (H)N(CA)NH NMR experiments with uniformly 
15N- and 13C-labeled samples in 10 mM Na3PO4, 50 mM NaCl, pH 6.4, 10% D2O, at 25 
°C. 3D HNCACB experiments were recorded with 512 (t3) × 64 (t2) × 42 (t1) complex 
data points for 1H, 13C and 15N dimensions, respectively, HN(CA)CO experiments with 
512 (t3) × 32 (t2) × 40 (t1) complex points,  CA(CO)NNH experiments with 512 (t3) × 44 
(t2) × 36 (t1) complex points, HNCO experiments with 512 (t3) × 48 (t2) × 64 (t1) complex 
points, (H)N(CA)NH experiments with 512 (t3) × 44 (t2) × 44 (t1) complex points. 2D 
HSQC experiments were recorded with 512 (t2) × 128 (t1) complex points. All 3D NMR 
spectra were processed with Topspin 3.1 and analyzed in CcpNMR. Final 1H and 15N 
amide assignments at pH 6.8 and 298 K were obtained by following progressive cross-
peak displacements from pH 6.4 and 277 K to pH 6.4 and 298 K (5 steps: 277 K, 283 K, 
288 K, 293 K, 298 K), and from pH 6.4 and 298 K to pH 6.8 and 298 K. Assignments of 
unmodified and phosphorylated wild-type Elk-1 TAD, as well as details of NMR 
experiments used to derive them have been deposited in the Biological Magnetic 
Resonance Data Bank (BMRB, accession numbers 26762 and 26786, respectively). 
 For time-resolved NMR monitoring of Elk-1 phosphorylation reactions, samples 
were reconstituted with 15N isotope-labeled Elk-1 TAD (50 µM in 100 µl sample volume 
10 mM Na3PO4, 50 mM NaCl, 1 mM ATP, 2 mM DTT, 5 mM MgCl2, 10% D2O, pH 6.9) 
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and 400 U ERK2 (NEB), or 200 U p38α (Signal Chem), 375 U JNK1, or 375 U JNK2 
(both Proqinase) at 25 °C. Progressive phosphorylation was analyzed and quantified as 
described previously (20). Error bars represent the precision with which individual 
phosphorylation levels were determined for each time point. They reflect the number of 
uniquely resolved chemical shifts whose peak intensities reported on the modification 
states of respective ERK2 sites (i.e. phosphorylated serines and threonines, and flanking 
residues). Intensities of at least two independent NMR signals reporting on the same 
phosphorylation event were combined for each time point (determined relative to 
normalized intensities of fully modified sites). Larger error bars represent sites for which 
fewer signals were combined (= 2), smaller error bars correspond to sites for which 
greater numbers of peak intensities were integrated (> 2). For measurement points 
without error bars, the determined experimental precision is smaller than the chosen point 
size. All time-resolved NMR measurements of individual phosphorylation reactions were 
repeated on at least two independent replicate samples (n=2) under identical experimental 
conditions and with the same kinase batch. Error bars reflecting the reproducibility of 
such measurements are smaller than the chosen point size (ie the circles in the figures; 
not shown).  
Consecutive 2D 1H-15N SOFAST-HQMC experiments were recorded with 64 scans, 
40 ms interscan delays, and 512 (t2) × 64 (t1) complex points. Individual acquisition times 
were 15 min and 30 s. All NMR spectra were processed by linear prediction in the 15N 
dimension (64 complex points), cosine-bell apodization and zero filling to 4,096 (t2) and 
2,048 (t1) data points, processed with Topspin 3.1 and analyzed in Sparky. Assignment of 
NMR signals of phosphorylated WT and mutant Elk-1 TAD was based on additional sets 
of 3D HNCACB experiments and de-novo backbone assignment procedures. Combined 
1H and 15N, 13CO chemical shift differences (Δδ) between unmodified and 
phosphorylated Elk-1 TAD were calculated as Δδ = [(Δδ HN2 + (Δδ N*0.154) 2 + (Δδ 
CO*0.351) 2)1/2]/3 and plotted for each residue, except prolines (31). Secondary structure 
propensities of unmodified and phosphorylated Elk-1 TAD were obtained with the 
neighbor-corrected structural propensity calculator (32, 33) (http://nmr.chem.rug.nl/cgi-
bin/selection_screen_ncSPC.py) using experimentally determined Cα and Cβ chemical 
shifts as input. Random coil chemical shift values of glycines preceding prolines were 
corrected to –0.77 p.p.m. according to (34). Similarly, random coil chemical shift values 
of phosphorylated serines and threonines were corrected as outlined in (35), also by 
taking pH-dependent chemical shift changes into account (36). Hence, the following 
correction values were used for chemical shift measurements at pH 6.9: For pSer, 
δ(Cα)corr= δ(Cα)+0.012 and δ(Cβ)corr= δ(Cβ)-1.865, for pThr, δ(Cα)corr= δ(Cα)-1.16 and 
δ(Cβ)corr= δ(Cβ)-2.33 (in p.p.m.).  
 
Multisite phosphorylation model 
The rate of Elk-1 phosphorylation in vitro is dependent on the concentration of 
ERK2 (fig. S3A), suggesting an apparently distributive phosphorylation mechanism 
where ERK2 modifies one phosphorylation site per docking encounter with Elk-1 (37). 
Since Elk-1 is released from ERK2 after each phosphorylation step, at each substrate 
encounter the different phosphorylation sites will effectively compete for ERK2. To 
simplify the mathematical treatment, we arbitrarily grouped the slower phosphorylation 
sites according to their distance from the midpoint between the two fastest sites (Fast, 
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T369 and S384; Intermediate: T354, T364, S389; Slow, T337, T418, S423), with 
decreasing relative affinities for ERK2 (ie KMFast < KMInt < KMSlow). The phosphorylation 
kinetics for wild-type Elk-1, with the Fast, Intermediate, and Slow sites were fitted 
according to equations 1 and 2 (20, 38). These equations describe the kinetics for a pair 
of sites competing for ERK2. As illustrated, equations (1) and (2) represent the relation 
between the Fast and Slow sites; similar equations can be applied to describe the other 
pairwise relationships between the different site classes. The δ value, defined in equation 
2, indicates the degree of competition between the sites (δ=1 denotes equal competition 
between sites, while 0<δ<<1 denotes weak competition). 
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Where:  
[S] is concentration of the phosphorylation sites; KMFast, KMInt and KMSlow are the apparent 
Michaelis-Menten constants for the Fast, Intermediate and Slow groups of sites 
respectively; VmaxFast, VmaxInt and VmaxSlow are maximum rates of phosphorylation for the 
Fast, Intermediate and Slow groups of sites respectively (proportional to the modification 
turnover rates); δ is the competitive index. Note that Equation 2 is a corrected form (20, 
39). Complete derivation of these kinetic formulas is published elsewhere (20, 38). 
 
 The observed data for the wild-type protein were fitted to the competition model 
in Fig. 2B, left panel, which defined the parameters that determine the δ values as:
 
S[ ]( t=0)
KM
fast  
= 12.7, 
S[ ]( t=0)
KM
int  = 3.34, 
S[ ](t=0)
KMslow
 = 2.65, 
Vmax
fast
K M
fast =0.14 min
-1,
 
Vmax
int
KM
int  = 0.029 min-1, and δ values as: 
Fast vs Slow, δ =  0.10; Fast vs Int, δ =  0.26; Int vs Slow, δ = 0.43. 
The data for the different Elk-1 mutants were then modeled assuming that the 
competitive relationships between the different types of sites are maintained in the 
mutants, and that mutated sites have negligible affinity for the kinase. The Elk-1F mutant 
data fit the model well, with the kinetics of intermediate and slow site phosphorylation in 
the mutant approaching those of the wild-type fast and intermediate sites respectively 
(Fig. 2B, center). The Elk-1I mutant data also fitted the model well, with the kinetics of 
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the fast sites increasing relative to wild-type, and the rate of slow site phosphorylation 
approaching that of the intermediate sites in wild-type Elk-1 (Fig. 2B, right). 
 
Expression and analysis of wild-type and mutant mouse Elk-1 in triply TCF-deficient 
MEFs 
 Triply TCF-deficient (TKO) MEFs, lacking Elk-1, Net, and SAP-1, were prepared 
from Elk1-/-;Elk3δ/δ;Elk4-/- embryos (40) and immortalized using SV40 T antigen (gift 
from Victoria Lawson). DNA encoding N-terminally flag-tagged full-length wild-type 
and mutant mouse Elk-1 were synthesized (GeneArt-Life technologies) and expressed 
using pMIG/MSCV-IRES-GFP (41). Cell sorting by GFP was used to isolate populations 
with similar levels of Elk-1 expression and confirmed by immunoblotting. Elk-1 mutants 
were: Elk-1F, T369A, S384A; Elk-1I, T354A, T364A, S390A; Elk-1S, T337A, T418A, 
S423A; Elk-1FI, T354A, T364A, T369A, S384A, S390A; Elk-1FW, F379A, W380A, 
Elk-1 T418A; Elk-1 S423A; Elk-1 T337A. 
For functional analysis, TKO cells expressing wild-type and mutant Elk-1 were 
grown in triplicate cultures in 6-well plates, serum-starved for 48 h, then stimulated with 
TPA. For gene expression analysis, RNA was prepared at the time of peak mRNA 
accumulation (Egr1, 45'; Egr2, 90'; Egr3, 120'; Fos, 45'; Nr4a1, 60'; Ier2, 45'), or over a 
time course, using the GenElute 96 well Total RNA purification kit (Sigma-Aldrich). 
cDNA was synthesized using the Transcriptor First Strand cDNA Synthesis Kit (Roche), 
and quantitative PCR was performed using an ABI 7900 thermocycler (Applied 
Biosystems) sequence detection system with SYBR green incorporation (Invitrogen, 
Carlsbad, CA). Relative abundance of template cDNA was calculated by the ΔCt method, 
normalizing to the abundance of Glyceradelhyde 3-phosphate dehydrogenase (GAPDH) 
cDNA. Primers for mRNA qPCR analysis were as described previously (40). Egr1 
intronic primers were TGATGTCTCCGCTGCAGATC and 
GGTGGGTGAGTGAGGAAAGG. For phosphorylation at 25 °C, cells were equilibrated 
at 25 °C for 1h before stimulation. Lysates for SDS-PAGE were prepared in 150 µl 2x 
SDS sample buffer and treated with Benzonase for 30 min, at 37 °C. Growth rates of 
TKO cells expressing wild-type and mutant Elk-1 were assessed by plating 2.5 x 104 cells 
in triplicate for each cell lines, with trypsinization and counting each day over 5 days. For 
siRNA depletion experiments, cells were transfected with 20 nmol siRNA 
oligonucleotides using Lipofectamine RNAi MAX (Invitrogen) Control siRNA was All 
Star (Qiagen). SMARTPOOL mouse MED23 siRNA was from Dharmacon. 
 
Immunoprecipitation, GST-fusion affinity assays, and antibodies 
Cells were lysed in PBS, 0.1% NP-40, 1 mM Na3VO4, 1mM okadaic acid and 
protease inhibitor cocktail (Roche Diagnostics), sonicated, and cleared by centrifugation 
for 15 min at 13000 rpm at 4 °C. For co-immunoprecipitation, lysates were incubated 
with 20 µl anti-flag M2 magnetic beads for 3 h at 4 °C. For GST-fusion protein affinity 
assays, 20 µl of gluthatione sepharose beads containing ~10 µg GST fusion protein, with 
binding for 3 h at 4 °C. Beads were washed 3 times with lysis buffer, and proteins were 
eluted with 20 µl of 1x SDS loading buffer. Standard transient transfection procedures 
were used to express HA-MED23 in NIH3T3 cells. Immunoprecipitation and GST fusion 
protein affinity assays were performed at least three times. Antibodies were: Flag 
(rabbit), flag M2 peroxidase (HRP), GST (rabbit), Sigma-Aldrich; GFP (rabbit), MCM6 
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(goat), Santa Cruz Biotechnology; MED23 (mouse), BD Biosciences; MED16 (rabbit), 
MED24 (rabbit), Bethyl Laboratories; ERK (panERK) (mouse), BD Transduction 
Laboratories; P-p44/42 MAPK (pERK) (rabbit), phospho-Elk-1(Ser383) (mouse), Cell 
Signaling; phospho-Elk-1(Thr363) (rabbit) phospho-Elk-1(Thr417) rabbit, in-house (6). 
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Fig. S1. 
 
 
 
Sequence conservation of human and mouse Elk-1, SAP-1 and Net TADs. Conserved 
S/T-P phosphorylation sites are highlighted according to Elk-1/ERK2 modification rates 
as fast, red; intermediate, blue; and slow, yellow. The D-box and FQFP kinase docking 
motifs are shown in green and the central FW Mediator-binding motif in purple. 
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Fig. S2 
 
NMR analysis of Elk-1 TAD phosphorylation by ERK2. (A) Time-resolved 2D NMR 
spectra of reconstituted phosphorylation reactions with 15N-labeled Elk-1 TAD (aa309-
429) and recombinant, unlabeled ERK2 at indicated reaction time-points. Phospho-site 
serine-threonine residues are color-coded according to their modification rates, i.e., fast 
(red), intermediate (blue) and slow (yellow). Progressive appearance of down-field 
shifted resonance cross-peaks, corresponding to phosphorylated serine-threonine 
residues, illustrates the time-dependent phosphorylation behavior of individual Elk-1 
TAD sites. Grey cross-peaks denote all other Elk-1 TAD residues. (B) Left, chemical 
shift difference (δΔ) analysis between unmodified and phosphorylated Elk-1 TAD with 
δΔ values plotted for each residue, except prolines, according to (31). As expected, Δδ 
values are highest for phosphorylated Elk-1 TAD residues, with minor changes for 
neighboring residues, and readily identify modified substrate sites. Right, residue-
resolved secondary structure propensity calculations for unmodified (black) and 
phosphorylated (red) Elk-1 TAD (32, 33)using experimentally determined Cα and Cβ 
chemical shift values as input. As can be appreciated from this plot, overall residual 
secondary structure propensities are below ~20 % in both forms of Elk-1 TAD and not 
substantially altered upon multisite phosphorylation. Hence, unmodified and 
phosphorylated Elk-1 TADs populate structural states that are largely disordered. 
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Fig. S3 
 
 
 
Time-resolved phosphorylation behavior of wild-type and mutant Elk1-TAD (A) SDS-
PAGE analysis of phosphorylation kinetics of GST-Elk-1 TAD using low and high 
amounts of ERK2. (B) Representative time-resolved modification curves of individual 
Elk-1 TAD sites upon phosphorylation with ERK2 using fast- (Elk-1F, T369A-S384A) 
and intermediate-site mutants (Elk-1I, T354A-T364A-S390A) as substrates, as well as 
fast-site aspartate-substituted Elk-1 TAD (Elk-1FD, T369D-S384D). (C) Representative 
time-resolved modification curves of individual Elk-1 sites upon phosphorylation with 
JNK1, JNK2 and p38 MAP kinases. Sites are color-coded according to their ERK2 rates. 
Elk-1 TAD phosphorylation by JNK exhibited a strong kinetic preference for T-P motifs, 
reminiscent of ERK2 phosphorylation of the FQFP mutant, and consistent with 
observations showing that JNK does not interact with the FQFP docking site (14, 15). 
TAD phosphorylation by p38 was more similar to ERK2 consistent with p38’s ability to 
interact with FQFP (25). 
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Fig. S4 
  
 
Reconstitution of TCF-deficient MEFs (TKO MEFs) with wild-type or mutant mouse 
Elk-1. (A) Reconstituted TKO cells expressing wild-type Elk-1, Elk-1F, Elk-1I, Elk-1S, 
Elk-1FI, or Elk-1FW at comparable levels, as confirmed by FACS analysis of the co-
expressed GFP marker and (B) immunoblotting with anti-Flag antibody.  (C) ERK 
activation upon TPA stimulation was comparable in all lines. (D) Comparison of TCF-
SRF target gene expression in wild-type MEFs and TCF-deficient MEFs (TKO MEFs) 
reconstituted with wild-type Elk-1. Cells were stimulated with TPA and transcripts 
quantified by qRT-PCR (relative to GAPDH RNA). Data are mean ± SEM (n=3).  (E-G) 
Reconstituted TKO cells expressing wild-type Elk-1, Elk-1S, Elk-1T418A, Elk-1S423A 
and Elk-1T337A. (E) Elk-1 protein levels were comparable, as confirmed by FACS 
analysis of the co-expressed GFP marker, and (F) immunoblotting with anti-Flag 
antibody (G) ERK activation upon TPA stimulation was comparable in all lines. 
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Fig. S5 
 
 
 
Effect of Elk-1 phosphorylation on Mediator interaction. (A) Mediator co-precipitation 
from unstimulated NIH3T3 cell extracts using wild-type GST-tagged Elk-1 TAD proteins 
phosphorylated for the indicated times with ERK2, detected by immunoblotting for 
MED23, MED16 and MED24. (B) Affinity precipitation as in (A) but from extracts of 
NIH3T3 cells transiently expressing HA-MED23. 
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Fig. S6 
 
 
Time course of Elk-1 phosphorylation and ERK activation upon differential TPA 
stimulation (A) Phosphorylation of fast (pS384), intermediate (pT364) and slow (pT418) 
Elk-1 sites in TCF-deficient MEFs reconstituted with mouse Elk-1 mutants upon 
stimulation with 50 ng/ml TPA at 25° C. (B) Immunoblot analysis of ERK 
phosphorylation/activation in MEFs reconstituted with wild-type Elk-1 and stimulated 
with increasing amounts of TPA at 37° C.  
 
